These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 2691314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases.
    Lamers CB.
    Digestion; 1989; 44 Suppl 1():92-5. PubMed ID: 2691316
    [Abstract] [Full Text] [Related]

  • 3. Omeprazole and acid peptic disease.
    Piper DW, Yeomans ND, Shearman DJ.
    Med J Aust; 1991 Mar 18; 154(6):374-5. PubMed ID: 2000048
    [No Abstract] [Full Text] [Related]

  • 4. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J.
    Eur J Gastroenterol Hepatol; 1995 May 18; 7(5):467-75. PubMed ID: 7614110
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Omeprazole.
    Walan A.
    Baillieres Clin Gastroenterol; 1988 Jul 18; 2(3):629-40. PubMed ID: 3048454
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proton pump inhibitors.
    Grover JK, Vats V.
    Trop Gastroenterol; 1999 Jul 18; 20(1):16-28. PubMed ID: 10464444
    [No Abstract] [Full Text] [Related]

  • 9. [Omeprazole. Its pharmacology and therapeutic efficacy].
    Protzer U, Holtermüller KH.
    Dtsch Med Wochenschr; 1993 Feb 19; 118(7):230-9. PubMed ID: 8440164
    [No Abstract] [Full Text] [Related]

  • 10. Clinical utility and safety of omeprazole.
    Walan A.
    Methods Find Exp Clin Pharmacol; 1989 Feb 19; 11 Suppl 1():107-11. PubMed ID: 2657279
    [Abstract] [Full Text] [Related]

  • 11. [Omeprazole and maintenance treatment: new concepts for traditional therapies?].
    Díaz de Rojas F, Ponce García J.
    An Med Interna; 1992 Sep 19; 9(9):450-4. PubMed ID: 1391583
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic achlorhydria: for which diseases, when and for how long?].
    Koop H, Arnold R.
    Dtsch Med Wochenschr; 1988 Mar 31; 113(13):516-8. PubMed ID: 2894969
    [No Abstract] [Full Text] [Related]

  • 13. Clinical experience with omeprazole: assessment of efficacy and safety.
    Walan A.
    J Gastroenterol Hepatol; 1989 Mar 31; 4 Suppl 2():27-33. PubMed ID: 2491359
    [Abstract] [Full Text] [Related]

  • 14. Criteria for use of omeprazole in adult inpatients and outpatients.
    Lajoie C.
    Clin Pharm; 1992 Feb 31; 11(2):177-9. PubMed ID: 1551300
    [No Abstract] [Full Text] [Related]

  • 15. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E.
    Leber Magen Darm; 1994 Mar 31; 24(2):66-8, 71. PubMed ID: 8196467
    [Abstract] [Full Text] [Related]

  • 16. [Lansoprazol].
    Ponce J, Nos P.
    Gastroenterol Hepatol; 1995 Feb 31; 18(2):101-9. PubMed ID: 7621274
    [No Abstract] [Full Text] [Related]

  • 17. Clinical development programme for omeprazole.
    Walan A.
    Digestion; 1990 Feb 31; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
    [Abstract] [Full Text] [Related]

  • 18. [Drug therapy of ulcer and reflux esophagitis. Recommendations from a group of experts].
    Lakartidningen; 1993 Jul 14; 90(28-29):2530-2. PubMed ID: 8326797
    [No Abstract] [Full Text] [Related]

  • 19. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
    Piai G, Sabbatini F, Mazzacca G.
    Ann Ital Chir; 1990 Jul 14; 61(1):11-4. PubMed ID: 1978622
    [No Abstract] [Full Text] [Related]

  • 20. Omeprazole: a comprehensive review.
    Massoomi F, Savage J, Destache CJ.
    Pharmacotherapy; 1993 Jul 14; 13(1):46-59. PubMed ID: 8437967
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.